2.5. BCR-ABL Monitoring Testing and the Use of Tyrosine Kinase Inhibitors (TKI)s in Chronic Myeloid Leukemia (CML). The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.